$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
卡博替尼+奥希替尼治疗继发克唑替尼耐药MET突变的肺腺癌
2025-10-19 11:44:20
Check Details
卡博替尼治疗放射学进展性甲状腺髓样癌: III期EXAM研究最新数据
2025-10-19 11:44:20
Check Details
卡博替尼用于晚期肾癌患者的一线治疗
2025-10-19 11:44:20
Check Details
奥希替尼和舒尼替尼那个治疗肾癌效果好
2025-10-19 11:44:20
Check Details
舒尼替尼一线治疗晚期RCC的疗效
2025-10-19 11:44:20
Check Details
舒尼替尼与Keytruda+Inlyta组合治疗肾癌的疗效
2025-10-19 11:44:20
Check Details
舒尼替尼治疗中国晚期肾癌患者
2025-10-19 11:44:20
Check Details
肾癌靶向新药帕唑帕尼
2025-10-19 11:44:20
Check Details
肾癌靶向药物帕唑帕尼和舒尼替尼
2025-10-19 11:44:20
Check Details
帕唑帕尼治疗肾癌的疗效
2025-10-19 11:44:20
Check Details
阿西替尼肾癌靶向药物
2025-10-19 11:44:20
Check Details
卡博替尼与依维莫司治疗肾癌的临床数据
2025-10-19 11:44:20
Check Details
1
2
...
2098
2099
2100
2101
2102
2103
2104
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
2
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
3
Adagrasib Medication Management Guide for Special Populations
4
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
5
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
6
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
7
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
8
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
9
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
10
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
11
Complete Guide to Dosage and Dose Adjustment of Entrectinib
12
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer